SILK ROAD MEDICAL, INC. Research and Development Expense
SILK ROAD MEDICAL, INC. reported Research and Development Expense of $11.88 million for the 3-month period ending 2024-06-30, per its 10-Q filed 2024-08-07.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2024-08-07
- SILK ROAD MEDICAL, INC. research and development expense for the quarter ending 2024-06-30 was $11.88M, a 10.23% increase year-over-year.
- SILK ROAD MEDICAL, INC. research and development expense for the quarter ending 2024-03-31 was $10.66M, a 2.18% increase year-over-year.
- SILK ROAD MEDICAL, INC. research and development expense for the quarter ending 2023-12-31 was $10.06M, a 9.39% increase year-over-year.
- SILK ROAD MEDICAL, INC. research and development expense for the quarter ending 2023-09-30 was $10.05M, a 18.60% increase year-over-year.
- SILK ROAD MEDICAL, INC. research and development expense for fiscal 2023 was $41.32M, a 13.37% increase from fiscal 2022.
- SILK ROAD MEDICAL, INC. research and development expense for fiscal 2022 was $36.45M, a 34.45% increase from fiscal 2021.
- SILK ROAD MEDICAL, INC. research and development expense for fiscal 2021 was $27.11M, a 27.45% increase from fiscal 2020.
- SILK ROAD MEDICAL, INC. research and development expense for fiscal 2020 was $21.27M, a 73.33% increase from fiscal 2019.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2024-06-30 | $11.88M 10-Q · filed 2024-08-07 | $22.54M 10-Q · filed 2024-08-07 | $32.61M derived: sum of 3 quarters · filed 2024-08-07 | $42.65M derived: sum of 4 quarters · filed 2024-08-07 |
| 2024-03-31 | $10.66M 10-Q · filed 2024-05-07 | $20.72M derived: sum of 2 quarters · filed 2024-05-07 | $30.77M derived: sum of 3 quarters · filed 2024-05-07 | $41.55M derived: sum of 4 quarters · filed 2024-08-07 |
| 2023-12-31 | $10.06M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $20.11M derived: sum of 2 quarters · filed 2024-02-28 | $30.89M derived: sum of 3 quarters · filed 2024-08-07 | $41.32M 10-K · filed 2024-02-28 |
| 2023-09-30 | $10.05M 10-Q · filed 2023-11-08 | $20.83M derived: sum of 2 quarters · filed 2024-08-07 | $31.26M 10-Q · filed 2023-11-08 | $40.46M derived: sum of 4 quarters · filed 2024-08-07 |
| 2023-06-30 | $10.78M 10-Q · filed 2024-08-07 | $21.21M 10-Q · filed 2024-08-07 | $30.41M derived: sum of 3 quarters · filed 2024-08-07 | $38.88M derived: sum of 4 quarters · filed 2024-08-07 |
| 2023-03-31 | $10.43M 10-Q · filed 2024-05-07 | $19.63M derived: sum of 2 quarters · filed 2024-05-07 | $28.10M derived: sum of 3 quarters · filed 2024-05-07 | $38.76M derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | $9.20M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $17.67M derived: sum of 2 quarters · filed 2024-02-28 | $28.33M derived: sum of 3 quarters · filed 2024-02-28 | $36.45M 10-K · filed 2024-02-28 |
| 2022-09-30 | $8.47M 10-Q · filed 2023-11-08 | $19.13M derived: sum of 2 quarters · filed 2023-11-08 | $27.25M 10-Q · filed 2023-11-08 | $34.75M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $10.65M 10-Q · filed 2023-08-08 | $18.78M 10-Q · filed 2023-08-08 | $26.28M derived: sum of 3 quarters · filed 2024-02-28 | $33.14M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $8.12M 10-Q · filed 2023-05-09 | $15.62M derived: sum of 2 quarters · filed 2024-02-28 | $22.49M derived: sum of 3 quarters · filed 2024-02-28 | $29.75M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $7.50M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $14.37M derived: sum of 2 quarters · filed 2024-02-28 | $21.63M derived: sum of 3 quarters · filed 2024-02-28 | $27.11M 10-K · filed 2024-02-28 |
| 2021-09-30 | $6.87M 10-Q · filed 2022-11-09 | $14.13M derived: sum of 2 quarters · filed 2022-11-09 | $19.61M 10-Q · filed 2022-11-09 | $29.65M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $7.26M 10-Q · filed 2022-08-09 | $12.74M 10-Q · filed 2022-08-09 | $22.78M derived: sum of 3 quarters · filed 2023-02-28 | $27.50M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | $5.48M 10-Q · filed 2022-05-10 | $15.52M derived: sum of 2 quarters · filed 2023-02-28 | $20.23M derived: sum of 3 quarters · filed 2023-02-28 | $23.63M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | $10.04M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $14.75M derived: sum of 2 quarters · filed 2023-02-28 | $18.14M derived: sum of 3 quarters · filed 2023-02-28 | $21.27M 10-K · filed 2023-02-28 |
| 2020-09-30 | $4.71M 10-Q · filed 2021-11-09 | $8.10M derived: sum of 2 quarters · filed 2021-11-09 | $11.23M 10-Q · filed 2021-11-09 | $14.50M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | $3.39M 10-Q · filed 2021-08-06 | $6.52M 10-Q · filed 2021-08-06 | $9.79M derived: sum of 3 quarters · filed 2022-03-01 | $12.97M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | $3.13M 10-Q · filed 2021-05-10 | $6.39M derived: sum of 2 quarters · filed 2022-03-01 | $9.58M derived: sum of 3 quarters · filed 2022-03-01 | $12.70M derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | $3.26M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $6.45M derived: sum of 2 quarters · filed 2022-03-01 | $9.56M derived: sum of 3 quarters · filed 2022-03-01 | $12.27M 10-K · filed 2022-03-01 |
| 2019-09-30 | $3.19M 10-Q · filed 2020-11-16 | $6.30M derived: sum of 2 quarters · filed 2020-11-16 | $9.01M 10-Q · filed 2020-11-16 | $12.40M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | $3.11M 10-Q · filed 2020-08-13 | $5.82M 10-Q · filed 2020-08-13 | $9.21M derived: sum of 3 quarters · filed 2021-03-01 | $11.65M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-03-31 | $2.71M 10-Q · filed 2020-05-15 | $6.10M derived: sum of 2 quarters · filed 2021-03-01 | $8.54M derived: sum of 3 quarters · filed 2021-03-01 | $10.87M derived: sum of 4 quarters · filed 2021-03-01 |
| 2018-12-31 | $3.39M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $5.83M derived: sum of 2 quarters · filed 2021-03-01 | $8.16M derived: sum of 3 quarters · filed 2021-03-01 | $10.26M 10-K · filed 2021-03-01 |
| 2018-09-30 | $2.44M 10-Q · filed 2019-11-13 | $4.77M derived: sum of 2 quarters · filed 2019-11-13 | $6.87M 10-Q · filed 2019-11-13 | |
| 2018-06-30 | $2.33M 10-Q · filed 2019-08-13 | $4.43M 10-Q · filed 2019-08-13 | ||
| 2018-03-31 | $2.10M 10-Q · filed 2019-05-15 |